Pentoxifylline vs Placebo or no active treatment
Difficulty in speech (participant-reported proxy) · People of any age with a confirmed diagnosis, by clinical examination and biopsy, of oral submucous fibrosis (OSF)
Pentoxifylline led to lower difficulty in speech (participant-reported proxy) compared with placebo or no active treatment; GRADE not reported.
1 finding from 1 review
- OR 0.20 [0.08, 0.48]1 study · 106 participantsGRADE not reported